Suppr超能文献

健康超重和肥胖女性通过饮食干预减肥对血清对氧磷酶 1 的生理内酯酶活性的影响。

Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

机构信息

Division of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.

出版信息

J Clin Biochem Nutr. 2009 Nov;45(3):329-34. doi: 10.3164/jcbn.09-26. Epub 2009 Oct 28.

Abstract

Low caloric diet (LCD) is used for weight loss. Paraoxonase 1 (PON-1) is associated with the antioxidant functions of high-density lipoprotein (HDL). Among limited data on the relationships between obesity and PON-1, there has been no study on the effects of a stand-alone LCD on the physiological lactonase activity of PON-1. We investigated the prospective effects of LCD intervention (2 months) for weight loss on serum PON-1 activities (lactonase, arylesterase [mono-esterase] and tri-esterase) and HDL cholesterol (HDL-C), and their association with low-density lipoprotein cholesterol (LDL-C) in overweight and non-morbidly obese but otherwise healthy women (n = 30; mean age, 50.3 years; mean body mass index [BMI], 28.5 kg/m(2)). In addition to the data such as BMI, blood pressure, blood glucose and lipids, PON-1 activities were examined between pre- and post-intervention. The intervention reduced all metabolic outcomes, and PON-1 lactonase activity (determined with 5-[thiobutyl]butyrolactone) significantly decreased by 6.1%, paralleled by arylesterase (by 7.3%) and tri-esterase (by 7.8%). In multiple regression analysis, the percent change of PON-1 lactonase was significantly, positively and independently correlated to that of LDL-C (beta = 0.51), HDL-C (beta = 0.40), and BMI (beta = 0.37). Our results showed that the solo diet treatment on weight loss might reduce serum PON-1 lactonase activity with reduced HDL-C and LDL-C. The relationship between the lactonase and LDL-C may be adaptive, plausibly hypothesizing less need for PON-1 activity as an antioxidant property to protect lipoproteins. Further research is needed to confirm this prediction.

摘要

低热量饮食(LCD)用于减肥。对氧磷酶 1(PON-1)与高密度脂蛋白(HDL)的抗氧化功能有关。在肥胖与 PON-1 之间关系的有限数据中,尚未有研究探讨单独的 LCD 对 PON-1 生理内酯酶活性的影响。我们研究了 LCD 干预(2 个月)减肥对超重且非病态肥胖但其他健康女性(n = 30;平均年龄 50.3 岁;平均 BMI[体重指数]28.5 kg/m²)血清 PON-1 活性(内酯酶、芳基酯酶[单酯酶]和三酯酶)和 HDL 胆固醇(HDL-C)的影响,及其与 LDL-C 的关系。除了 BMI、血压、血糖和血脂等数据外,还在干预前后检查了 PON-1 活性。干预降低了所有代谢结果,PON-1 内酯酶活性(用 5-[硫丁基]丁内酯测定)显著降低了 6.1%,芳基酯酶降低了 7.3%,三酯酶降低了 7.8%。在多元回归分析中,PON-1 内酯酶的百分比变化与 LDL-C(β=0.51)、HDL-C(β=0.40)和 BMI(β=0.37)呈显著正相关且独立相关。我们的结果表明,单独的饮食治疗对体重减轻可能会降低血清 PON-1 内酯酶活性,同时降低 HDL-C 和 LDL-C。内酯酶与 LDL-C 之间的关系可能是适应性的,推测是因为脂蛋白的抗氧化特性对 PON-1 活性的需求减少。需要进一步研究来证实这一预测。

相似文献

2
Increased PON lactonase activity in morbidly obese patients is associated with impaired lipid profile.
Int J Clin Pract. 2019 Jun;73(6):e13315. doi: 10.1111/ijcp.13315. Epub 2019 Feb 14.
7
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
J Clin Endocrinol Metab. 2005 Mar;90(3):1728-33. doi: 10.1210/jc.2004-0486. Epub 2004 Dec 21.
8
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
Scand J Clin Lab Invest. 2018 Feb-Apr;78(1-2):18-24. doi: 10.1080/00365513.2017.1405274. Epub 2017 Nov 23.
9
HDL subgroups and their paraoxonase-1 activity in the obese, overweight and normal weight subjects.
Int J Clin Pract. 2021 Dec;75(12):e14969. doi: 10.1111/ijcp.14969. Epub 2021 Oct 21.

引用本文的文献

1
Effect of Diet on HDL in Obesity.
Molecules. 2024 Dec 17;29(24):5955. doi: 10.3390/molecules29245955.
2
Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality.
Front Nutr. 2021 Nov 22;8:761170. doi: 10.3389/fnut.2021.761170. eCollection 2021.
3
Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.
Int J Mol Sci. 2020 Nov 26;21(23):8985. doi: 10.3390/ijms21238985.
4
Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.
J Vet Diagn Invest. 2021 Jan;33(1):59-66. doi: 10.1177/1040638720974745. Epub 2020 Nov 22.
7
Serum paraoxonase 1 (PON1) measurement: an update.
BMC Vet Res. 2014 Mar 25;10:74. doi: 10.1186/1746-6148-10-74.
8
Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.
J Physiol Biochem. 2014 Jun;70(2):603-14. doi: 10.1007/s13105-014-0316-5. Epub 2014 Feb 7.
9
Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.
Arch Med Sci. 2012 Feb 29;8(1):138-53. doi: 10.5114/aoms.2012.27294.
10

本文引用的文献

1
The role of dysfunctional HDL in atherosclerosis.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S145-9. doi: 10.1194/jlr.R800036-JLR200. Epub 2008 Oct 27.
2
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
Free Radic Biol Med. 2008 Sep 15;45(6):743-8. doi: 10.1016/j.freeradbiomed.2008.05.024. Epub 2008 Jun 6.
5
Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
Biochem Biophys Res Commun. 2007 Dec 7;364(1):157-62. doi: 10.1016/j.bbrc.2007.09.119. Epub 2007 Oct 4.
7
PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Kaohsiung J Med Sci. 2007 May;23(5):225-31. doi: 10.1016/S1607-551X(09)70402-4.
8
10
Orlistat increases serum paraoxonase activity in obese patients.
Nutr Metab Cardiovasc Dis. 2007 May;17(4):268-73. doi: 10.1016/j.numecd.2006.03.004. Epub 2006 Jul 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验